Active	Status	Sponsor type	Region	Phase	Filter
4 Active 1 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Li, Yongjun
NCT04275323: Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-1)	Completed	3	302	RoW	NL003, HGF plasmid, pCK-HGF-X7, Normal Saline, Placebo	Beijing Northland Biotech. Co., Ltd.	Arterial Occlusive Disease, Ischemia, Ulcers, Peripheral Vascular Disease	06/24	06/24
NL003-CLI-III-2, NCT04274049: Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia	Completed	3	242	RoW	NL003, HGF plasmid, pCK-HGF-X7, Normal Saline, Placebo	Beijing Northland Biotech. Co., Ltd.	Arterial Occlusive Disease, Ischemia, Ulcers, Peripheral Vascular Disease	12/23	12/23
NCT02698839: A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)	Active, not recruiting	N/A	539	RoW	BuMA Supreme, BuMA™	Sino Medical Sciences Technology Inc.	Coronary Artery Disease	03/18	12/25
GENIUS, NCT04849325: IBS Titan vs. PTA in Patients With Infrapopliteal Arterial Stenosis or Occlusive Disease	Recruiting	N/A	120	RoW	Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System (IBS Titanâ„¢), Percutaneous Transluminal Angioplasty (PTA) Device	Biotyx Medical (Shenzhen) Co., Ltd.	Critical Limb Ischemia (CLI)	04/24	10/24